Log in to your Inderes Free account to see all free content on this page.
Create account

I-tech

58.40 SEK

+4.10 %

Less than 1K followers

ITECH

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

+4.10 %
+21.16 %
+7.35 %
+11.88 %
-19.78 %
-25.32 %
-13.86 %
-21.08 %
+136.77 %

I-tech operates in marine technology. The company conducts research and development of substances that inhibit marine fouling on ship hulls. In addition, the products can be used for various marine installations in fish farming and offshore. Customers are found in the marine paint industry and among other players in the shipping industry. I-Tech was founded in 2000 and has its headquarters in Mölndal.

Read more
Market cap
700.67M SEK
Turnover
347.1K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
7.5.
2026

Interim report Q1'26

21.5.
2026

General meeting '26

22.5.
2026

Annual dividend

ShowingAll content types
Third party research

I-tech: Another growth breather in Q1e - ABG

* Q1e sales 42m (57m), adj. EBIT SEK 9.8m (18m) * Updated FX forecasts, we raise '26e-'28e sales by 4-5% * Trading at '26e-'28e EV/EBIT of 8x-3x Q1 expectations We estimate sales of SEK 42m (57m), -27% y-o-y (-15%% org., -12% FX). I-Tech is facing tough...

I-tech

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Third party research

I-tech: A pause in pace, not the story - ABG

* Q4: -23% organic growth (vs. ABGSCe -12%) * Financially constrained customer weighed on ’25 org. growth * Long-term potential intact, expect continued CMP growth in '26e 2025, a mixed financial year Q4 organic growth came in below our estimate at -...

I-tech
Third party research

I-tech: Customer pullback weighing on growth - ABG

Sales -13% vs. ABGSCe, EBIT SEK 7.6m vs. ABGSCe 9.4m * Three coating products launched in Korea in Q4 * Sizeable customer with financial constraints impacting volumes Q4 results I-Tech reported sales of SEK 39m, falling 13% short of our estimate (-33...

I-tech
Third party research

I-tech: No easy lap into Q4e - ABG

* Q4e sales SEK 45m (58m), adj. EBIT SEK 10m (19m) * We cut '26e-'27e sales and EBIT by 10% and 22-19%, respectively * Lowered growth assumptions for CMP Tough comps in Q4e We estimate Q4 sales of SEK 45m, -23% y-o-y (-12% organic, -11% FX). I-Tech is...

I-tech
Third party research

I-tech: Proposed non-renewal of Selektope in the EU - ABG

* European Commission drafts proposal for non-renewal of Selektope* Limited impact on near-term estimates, EU ~2% of total sales* Voting expected to occur some time in H1'26, final decision in mid-26European Commission drafts proposal for non-renewal...

I-tech
Third party research

I-tech: Customer slowdown tempers growth - ABG

* Q3 softer due to sizeable customer trimming '25 volumes* '25e-'27e sales cut by 11-6% and '26e-'27e EBIT by 12-8%* We believe I-Tech remains strongly positioned to grow market shareGrowth dampened by customer volume cutsI-Tech reported weaker than ...

I-tech
Third party research

I-tech: Q3 impacted by weaker market conditions - ABG

Sales -18% vs. ABGSCe, EBIT SEK 11m vs. ABGSCe 16m* Newbuild market down 50% y-o-y, affecting growth* Sizeable customer has reduced planned volumes for '25Q3 resultsQ3 sales came in lower than expected at SEK 41m (-18% vs. ABGSCe 50m). The company writes...

I-tech
Third party research

I-tech: Sales recovery expected in Q3 - ABG

* Report out on 17 October* Q3e sales of SEK 50m, +23% y-o-y, EBIT SEK 16m (9m)* Q3 rebound expected after Q2 dip Q3 expectations We estimate Q3 sales of SEK 50m, +23% y-o-y (+35% organic, -12% FX). We expect Q3 to demonstrate that Q2 was a temporary...

I-tech
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.